Geneza Pharma continues its tendency to overdose products with its testosterone enanthate product.
Geneza Pharma appears to intentionally overdose its products. The rationale for doing so seems driven by the desire to keep its customers happy. But is this the best marketing strategy?
Geneza Pharmaceuticals GP Test Enanth 250 supposedly contains 250 milligrams of testosterone enanthate per milliliter of injectable solution according to the product label. AnabolicLab put this claim to the test by sending an unopened product sample to SIMEC for quantitative dosage analysis.
New lab report: Geneza Pharmaceuticals GP Test Enanth 250 Lab Test Results https://t.co/ZVF1FRGhpK #harmreduction #steroids
— Anabolic Lab (@AnabolicLab) July 26, 2017
Geneza Pharma GP Test Enanth 250 contains more active ingredient than advertised.
SIMEC performed an HPLC-UV analysis on Geneza Pharma’s GP Test Enanth 250. The lab test results revealed that the product actually contained 301.5 mg/ml testosterone enanthate.
Geneza Pharma GP Test Enanth 250 contained 121% of the label claim. In other words, it was 21% overdosed. The product overdosing appears to be a trend among Geneza Pharma products.
While consumers may be happy with this lab test result, AnabolicLab rated the results as a “fail” because it deviate more than 20% from the label claim. Similarly, RoidVisor does not recommend this product because it is more than 10% overdosed.
An overdosed product is not the worst thing in the bodybuilding world. Most consumers would be more than satisfied. But it is simply not reflective of good quality control or truth in advertising by the manufacturer.
